A new 5-HT3 receptor ligand.: II.: Structure-activity analysis of 5-HT3 receptor agonist action in the gut

被引:0
|
作者
Yamada, M [1 ]
Sato, Y [1 ]
Kobayashi, K [1 ]
Konno, F [1 ]
Soneda, T [1 ]
Watanabe, T [1 ]
机构
[1] Meiji Seika Kaisha Ltd, Pharmaceut Res Ctr, Kohoku Ku, Yokohama, Kanagawa 222, Japan
关键词
1-allyl-1-methyl-4-(2-benzoxazolyl)piperazinium iodide (CP2289); 5-HT3; receptor; agonist;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Several modified 2-piperazinyl benzoxazole derivatives, which exhibit an agonistic effect on gastrointestinal motility, were synthesized and their effects on the contraction of guinea-pig ileum were examined, The quaternary piperazinyl benzoxazole structure has a restricted conformation and stereostructure compared to those of the other 5-HT3 receptor agonists, serotonin and meta-chlorophenylbiguanide. The mutual positions of the aromatic ring, nitrogen atom and terminal amine are considered to form the pharmacophore of the 5-HT3 receptor agonist in the gut. In the serotonin-evoked reflex bradycardia [Bezold-Jarisch (B-J) reflex] inhibition test using rats the B-J reflex-inducing ratio was different for each synthesized compound. These results suggest that, in these 5-HT3 receptor agonists, the substituents of the benzoxazole ring influence the B-J reflex-inducing activity in rats.
引用
收藏
页码:445 / 451
页数:7
相关论文
共 50 条
  • [31] Serotonin 5-HT3 and 5-HT4 receptor antagonists
    Gaster, LM
    King, FD
    MEDICINAL RESEARCH REVIEWS, 1997, 17 (02) : 163 - 214
  • [32] SELECTIVITY OF 5-HT3 RECEPTOR ANTAGONISTS AND ANTIEMETIC MECHANISMS OF ACTION
    FREEMAN, AJ
    CUNNINGHAM, KT
    TYERS, MB
    ANTI-CANCER DRUGS, 1992, 3 (02) : 79 - 85
  • [33] SR 57227A is a partial agonist/partial antagonist of 5-HT3 receptor and inhibits subsequent 5-HT- or SR 57227A-induced 5-HT3 receptor current
    Nakamura, Yukiko
    Kondo, Makoto
    Koyama, Yoshihisa
    Shimada, Shoichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 508 (02) : 590 - 596
  • [34] A new competitive ligand of 5-HT3 receptors
    Vitalis, B
    Csillik-Perczel, V
    Mate, G
    Barlocco, D
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S250 - S251
  • [35] 5-HT3 receptor antagonist for the treatment of tendinopathy
    Mousavizadeh, Kazem
    Stratz, Thomas
    Mueller, Wolfgang
    Fiebich, Bernd L.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (07): : E4 - E4
  • [36] Recent developments in 5-HT3 receptor pharmacology
    Thompson, Andrew J.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (02) : 100 - 109
  • [37] MOLECULAR MODELING OF 5-HT3 RECEPTOR LIGANDS
    EVANS, SM
    GALDES, A
    GALL, M
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (04) : 1033 - 1040
  • [38] Conformational transitions of the serotonin 5-HT3 receptor
    Lucie Polovinkin
    Ghérici Hassaine
    Jonathan Perot
    Emmanuelle Neumann
    Anders A. Jensen
    Solène N. Lefebvre
    Pierre-Jean Corringer
    Jacques Neyton
    Christophe Chipot
    Francois Dehez
    Guy Schoehn
    Hugues Nury
    Nature, 2018, 563 : 275 - 279
  • [39] The Central 5-HT3 Receptor in CNS Disorders
    Floyd E. Bloom
    Marisela Morales
    Neurochemical Research, 1998, 23 : 653 - 659
  • [40] The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats
    Nakagawa, Y
    Ishima, T
    Takashima, T
    BRAIN RESEARCH, 1998, 786 (1-2) : 189 - 193